美聯儲理事沃勒：通脹工作組可能對聯邦公開市場委員會最有幫助。

On the afternoon of Sept. 4, China's Ministry of National Defense spokesperson Colonel Jiang Bin said recent Taiwanese defense reports exaggerate a "mainland threat" and serve as an excuse for the Democratic Progressive Party to stoke war anxiety. He reiterated that the PLA routinely conducts ships-and-aircraft combat-readiness patrols around Taiwan to carry out anti-secession and anti-interference operations to safeguard China's sovereignty and territorial integrity, and warned any attempt to pursue independence by force would fail.

September 4 — Merck said China’s NMPA approved its PD‑1 inhibitor pembrolizumab for adults with resectable locally advanced head‑and‑neck squamous cell carcinoma whose tumors express PD‑L1 (combined positive score CPS ≥1) by a validated test. Approval covers single‑agent neoadjuvant use, postoperative adjuvant radiotherapy with or without cisplatin, and continued pembrolizumab monotherapy thereafter.